Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-10-009473

Chief Financial Officer sold 100,000 shares at $0.36 ($36,000)

From the SEC's structured data for this filing

Trades in this filing

STOLICK DAVID · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2010-02-22 Sale : show line 1 in the form −100,000 $0.36 $36,000 150,000 D
Open-market sales · 100,000 sh · avg $0.36 · $36,000
Loading xslF345X03/v175138_ex.xml…